We are live on ! Find out more
Neuberger Berman Group

Neuberger Berman Group Portfolio holdings

AUM $131B
1-Year Est. Return 28.36%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$108B
AUM Growth
+$5.83B
Cap. Flow
+$190M
Cap. Flow %
0.18%
Top 10 Hldgs %
14.94%
Holding
1,906
New
122
Increased
781
Reduced
810
Closed
98

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$264M
2
BSX icon
Boston Scientific
BSX
+$239M
3
MCD icon
McDonald's
MCD
+$234M
4
GILD icon
Gilead Sciences
GILD
+$215M
5
EXC icon
Exelon
EXC
+$214M

Sector Composition

Rank Sector Weight
1 Technology 23.58%
2 Financials 12.83%
3 Healthcare 12.57%
4 Industrials 11.46%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$346B
$647M 0.6%
6,993,888
+64,525
+0.9% +$5.66M
COST icon
27
Costco
COST
$411B
$624M 0.58%
1,255,344
-32,584
-3% -$16M
TMO icon
28
Thermo Fisher Scientific
TMO
$213B
$606M 0.56%
1,051,650
+52,225
+5% +$29.4M
DHR icon
29
Danaher
DHR
$135B
$584M 0.54%
2,615,703
-56,305
-2% -$12.8M
LSCC icon
30
Lattice Semiconductor
LSCC
$18.9B
$580M 0.54%
6,080,936
-124,187
-2% -$10.2M
MSI icon
31
Motorola Solutions
MSI
$67.6B
$569M 0.53%
1,987,848
-260,023
-12% -$68.6M
SRE icon
32
Sempra
SRE
$61.1B
$568M 0.53%
7,514,612
+1,247,336
+20% +$95.7M
REGN icon
33
Regeneron Pharmaceuticals
REGN
$68.3B
$566M 0.52%
688,879
+39,229
+6% +$29.6M
PFE icon
34
Pfizer
PFE
$143B
$563M 0.52%
13,798,483
+1,456,337
+12% +$62.9M
MA icon
35
Mastercard
MA
$469B
$556M 0.52%
1,529,122
+9,316
+0.6% +$3.38M
UNH icon
36
UnitedHealth
UNH
$385B
$528M 0.49%
1,116,948
+157,401
+16% +$76M
RIO icon
37
Rio Tinto
RIO
$149B
$525M 0.49%
7,652,228
+1,404,275
+22% +$102M
ASML icon
38
ASML
ASML
$693B
$521M 0.48%
765,560
-25,735
-3% -$16.5M
UNP icon
39
Union Pacific
UNP
$181B
$517M 0.48%
2,569,991
-28,930
-1% -$5.86M
SPGI icon
40
S&P Global
SPGI
$124B
$496M 0.46%
1,437,870
-79,500
-5% -$28M
LLY icon
41
Eli Lilly
LLY
$1.06T
$483M 0.45%
1,406,112
+75,211
+6% +$25.4M
CDW icon
42
CDW
CDW
$16.6B
$480M 0.45%
2,462,449
-130,792
-5% -$25.7M
APD icon
43
Air Products & Chemicals
APD
$65.5B
$477M 0.44%
1,663,389
-82,868
-5% -$24.2M
CSX icon
44
CSX Corp
CSX
$97.8B
$477M 0.44%
15,927,375
-1,373,460
-8% -$42.2M
EPD icon
45
Enterprise Products Partners
EPD
$83.9B
$472M 0.44%
18,211,122
-483,473
-3% -$12.4M
BSX icon
46
Boston Scientific
BSX
$64.8B
$465M 0.43%
9,304,889
+5,068,740
+120% +$239M
DUK icon
47
Duke Energy
DUK
$101B
$443M 0.41%
4,593,878
+1,580,546
+52% +$156M
PEP icon
48
PepsiCo
PEP
$184B
$439M 0.41%
2,409,473
+768,318
+47% +$134M
TJX icon
49
TJX Companies
TJX
$170B
$434M 0.4%
5,541,389
+558,561
+11% +$43.9M
WMT icon
50
Walmart Inc
WMT
$863B
$433M 0.4%
8,803,668
+1,736,676
+25% +$82.4M

Similar funds

Neuberger Berman Group's Q1 2023 Portfolio in Review

As of Q1 2023, Neuberger Berman Group held 1,906 positions worth $108B, up 5.7% from $102B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Neuberger Berman Group's Q1 2023 filing shows 122 new, 781 increased, 810 reduced and 98 closed positions. Its largest new stake was Tidewater: 3,064,214 shares worth $135M. The largest sale was Parker-Hannifin, an estimated $231M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Neuberger Berman Group's largest Q1 2023 buy was Tidewater: 3,064,214 shares worth $135M.
  • Neuberger Berman Group added most to Johnson & Johnson in Q1 2023, an estimated $264M increase.
  • Neuberger Berman Group's biggest Q1 2023 reduction was Parker-Hannifin, cutting an estimated $231M.
  • Neuberger Berman Group fully exited SVB Financial Group in Q1 2023, selling an estimated $123M.
  • Neuberger Berman Group's ten largest holdings make up 15% of its $108B portfolio in Q1 2023.
  • Neuberger Berman Group opened 122 new positions and closed 98 in Q1 2023.
  • Neuberger Berman Group's portfolio value rose 5.7% quarter-over-quarter to $108B.

Based on Neuberger Berman Group's 13F filing for Q1 2023, filed 12 May 2023.